Syncom Formulations (India) Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
SYNCOMF · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Syncom Formulations has informed the exchanges that the trading window for its shares will be closed from October 1, 2025 until 48 hours after the declaration of unaudited financial results for Q2 and the half year ended September 30, 2025. This is a standard compliance step required under SEBI's insider trading regulations, meaning insiders such as promoters, directors, key managerial personnel, designated employees, connected persons, fiduciaries and their immediate relatives cannot buy or sell the company's shares during this period. The PANs of these insiders will be frozen at the depository (CDSL) level for security purposes. The actual board meeting date to approve the Q2 results has not yet been disclosed and will be communicated later.
This is a routine regulatory filing with no direct impact on shareholders or the stock price. It signals that Q2 FY26 results are expected in the coming weeks, which investors should watch for as the next catalyst.